KRRO is trading at $14.45 (5.4% up) as the speculative small-cap biotech extends its strong multi-day rally from mid-June.
- The move appears driven by ongoing momentum, volatility, and profit-taking dynamics following recent double-digit gains in the stock.
- There is no new major company-specific news or regulatory filings today to account for the continued upward price action.